The increase in minimal microvascular resistance that occurs with age may result in progressive impaired capacity of coronary vasodilation in the pan myocardial region, and may affect ischemic heart disease pathophysiology, according to a study published in JACC: Cardiovascular Interventions. This study included 327 patients (with a total of 419 stenosed vessels), all of whom had a clinical indication for physiological examination of at least 1 intermediate angiographic severity Continue reading →

Non-vitamin K antagonist oral anticoagulants (NOACs) may be associated with lower risks for adverse events requiring hospitalization and reduced rates of major bleeding compared with vitamin K antagonists in patients receiving percutaneous coronary intervention (PCI) for non-valvular atrial fibrillation who have an indication for anticoagulation, according to study results published in Cochrane Database Systematic Review. In this systematic review and network meta-analysis, the data of randomized controlled trials indexed in CENTRAL, MEDLINE, Embase, the Conference Proceedings Citation Index Science, and 2 clinical trial registers, in which the outcomes of patients with an indication for anticoagulation who had undergone PCI and treated with NOACs vs vitamin K antagonists were examined. The final network meta-analysis included 5 randomized controlled trials with a pooled cohort of 8373 participants. Continue reading →

Habitual tea consumption is associated with lower risk of cardiovascular disease and death, according to a study published last week in the European Journal of Preventive Cardiology. Continue reading →

Cardiologs, a French medical technology startup thats leveraging artificial intelligence (AI) to help detect heart conditions, has raised $15 million in series A funding. The round was led by Paris-based venture capital (VC) firm Alven, which touts its credentials for helping French-founded startups expand into the U.S. Other participants include Bpifrance, Idinvest Partners, Kurma Diagnostics, ISAI, and Paris Saclay Seed Fund. Continue reading →

Heart disease is the Number 1 killer in the United States. Too few people covered by Medicare participated in outpatient cardiac rehabilitation after a heart attack or acute heart event or surgery, particularly women, the elderly and non-white patients, according to new research published today in the American Heart Associations journalCirculation: Cardiovascular Quality and Outcomes. Every year, an estimated 1.3 million U.S. Continue reading →